PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease

Youness Limami; Nezha Senhaji; Nabil Zaid; Loubna Khalki; Abdallah Naya; Najia Hajjaj-Hassouni; Farid Jalali; Mounia Oudghiri; Younes Zaid

doi:10.1055/s-0041-1736571

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2022; 48(02): 246-250
DOI: 10.1055/s-0041-1736571

Letter to the Editor

PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease

Youness Limami

¹Department of Biology, Faculty of Sciences Ain Chock, Immunology and Biodiversity Laboratory, Hassan II University, Casablanca

²Department of Medicine, Research Center of Abulcasis University of Health Sciences, Rabat, Morocco

,

Nezha Senhaji

³Faculty of Medicine, Laboratory of Genetic and Molecular Pathology, Hassan II University, Casablanca, Morocco

,

Nabil Zaid

⁴Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco

,

Loubna Khalki

⁵Faculty of Medicine, Research Center, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco

,

Abdallah Naya

¹Department of Biology, Faculty of Sciences Ain Chock, Immunology and Biodiversity Laboratory, Hassan II University, Casablanca

,

Najia Hajjaj-Hassouni

⁶Department of Medicine, International University of Rabat, Rabat, Morocco

,

Farid Jalali

⁷Department of Gastroenterology, Saddleback Medical Group, Laguna Hills, California

,

Mounia Oudghiri

¹Department of Biology, Faculty of Sciences Ain Chock, Immunology and Biodiversity Laboratory, Hassan II University, Casablanca

,

Younes Zaid

¹Department of Biology, Faculty of Sciences Ain Chock, Immunology and Biodiversity Laboratory, Hassan II University, Casablanca

²Department of Medicine, Research Center of Abulcasis University of Health Sciences, Rabat, Morocco

⁴Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco

› Author Affiliations

Abstract

Full Text

References

References
1 Senhaji N, Nadifi S, Zaid Y. et al. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease. World J Gastroenterol 2017; 23 (47) 8300-8307
2 Marafini I, Troncone E, Salvatori S, Monteleone G. TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases. Pharmacol Res 2020; 155: 104757
3 Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115 (01) 182-205
4 Fiocchi C. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 1997; 273 (04) G769-G775
5 Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1 (09) 1897-1905
6 Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11 (04) 264-274
7 Allaoui A, Khawaja AA, Badad O. et al. Platelet Function in Viral Immunity and SARS-CoV-2 Infection. Semin Thromb Hemost 2021; 47 (04) 419-426
8 Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010; 67 (04) 499-511
9 Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 2013; 35 (03) 254-261
10 Senhaji N, Kojok K, Darif Y, Fadainia C, Zaid Y. The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update. Front Immunol 2015; 6: 529
11 Zaid Y, Guessous F, Puhm F. et al. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19. Blood Adv 2021; 5 (03) 635-639
12 Zaid Y, Puhm F, Allaeys I. et al. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res 2020
13 Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 2010; 8 (03) 454-462
14 Heemskerk JW, Harper MT, Cosemans JM, Poole AW. Unravelling the different functions of protein kinase C isoforms in platelets. FEBS Lett 2011; 585 (12) 1711-1716
15 Hall KJ, Harper MT, Gilio K, Cosemans JM, Heemskerk JW, Poole AW. Genetic analysis of the role of protein kinase Ctheta in platelet function and thrombus formation. PLoS One 2008; 3 (09) e3277
16 Pears CJ, Thornber K, Auger JM. et al. Differential roles of the PKC novel isoforms, PKCdelta and PKCepsilon, in mouse and human platelets. PLoS One 2008; 3 (11) e3793
17 Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J 2004; 384 (Pt 3): 449-459
18 Yacoub D, Théorêt JF, Villeneuve L. et al. Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release. J Biol Chem 2006; 281 (40) 30024-30035
19 Chari R, Getz T, Nagy Jr B. et al. Protein kinase C[delta] differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol 2009; 29 (05) 699-705
20 Liverani E, Mondrinos MJ, Sun S, Kunapuli SP, Kilpatrick LE. Role of protein kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis. PLoS One 2018; 13 (04) e0195379
21 Kostyak JC, Bhavanasi D, Liverani E, McKenzie SE, Kunapuli SP. Protein kinase C δ deficiency enhances megakaryopoiesis and recovery from thrombocytopenia. Arterioscler Thromb Vasc Biol 2014; 34 (12) 2579-2585
22 Kilpatrick LE, Sun S, Mackie D, Baik F, Li H, Korchak HM. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2. J Leukoc Biol 2006; 80 (06) 1512-1521
23 Kilpatrick LE, Standage SW, Li H. et al. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC). J Leukoc Biol 2011; 89 (01) 3-10
24 Chen L, Hahn H, Wu G. et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A 2001; 98 (20) 11114-11119
25 Zaid Y, Marhoume F, Senhaji N. et al. Paraphenylene diamine exacerbates platelet aggregation and thrombus formation in response to a low dose of collagen. J Toxicol Sci 2016; 41 (01) 123-128
26 Caron A, Théorêt JF, Mousa SA, Merhi Y. Anti-platelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils. J Cardiovasc Pharmacol 2002; 40 (02) 296-306
27 Curtis MJ, Alexander S, Cirino G. et al. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol 2018; 175 (07) 987-993
28 Zaid Y, Senhaji N, Naya A, Fadainia C, Kojok K. PKCs in thrombus formation. Pathol Biol (Paris) 2015; 63 (06) 268-271
29 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
30 Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2357-2361
31 Crosby D, Poole AW. Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets. J Biol Chem 2003; 278 (27) 24533-24541
32 Pula G, Schuh K, Nakayama K, Nakayama KI, Walter U, Poole AW. PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood 2006; 108 (13) 4035-4044
33 Zaid Y, Senhaji N, Darif Y, Kojok K, Oudghiri M, Naya A. Distinctive roles of PKC delta isozyme in platelet function. Curr Res Transl Med 2016; 64 (03) 135-139
34 Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP. Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets. Blood 2005; 106 (02) 550-557
35 Hall KJ, Jones ML, Poole AW. Coincident regulation of PKCdelta in human platelets by phosphorylation of Tyr311 and Tyr565 and phospholipase C signalling. Biochem J 2007; 406 (03) 501-509
36 Soroush F, Tang Y, Guglielmo K. et al. Protein kinase C-Delta (PKCδ) tyrosine phosphorylation is a critical regulator of neutrophil-endothelial cell interaction in inflammation. Shock 2019; 51 (05) 538-547